Medpace Holdings, Inc. (MEDP) Current vs Average EV/Sales Ratio
How Medpace Holdings, Inc. (MEDP)'s current ev/sales ratio of 4.74x compares to its TTM/3Y/5Y/10Y/15Y/20Y averages as of Thursday, June 18, 2026.
Current vs Average EV/Sales Ratio Chart
MEDP EV/Sales Ratio vs Average
CURRENT VS TTM AVG
-21.22%
CURRENT VS 3Y AVG
-14.59%
CURRENT VS 5Y AVG
-12.13%
CURRENT VS 10Y AVG
+1.12%
CURRENT VS 15Y AVG
+1.12%
CURRENT VS 20Y AVG
+1.12%
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle